Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.

Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy. Acta Radiol. 2020 Feb 13;:284185120903139 Authors: Xu L, Ge X, Sun N, Liu X PMID: 32053003 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32053003?dopt=Abstract

Source: Acta Radiologica - February 12, 2020 Category: Radiology Authors: Xu L, Ge X, Sun N, Liu X Tags: Acta Radiol Source Type: research

More News: Cancer & Oncology | Carcinoma | Esophagus Cancer | Radiology